KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Cost of Revenue: 2017-2024

Historic Cost of Revenue for BeOne Medicines (ONC) over the last 8 years, with Dec 2024 value amounting to $594.1 million.

  • BeOne Medicines' Cost of Revenue rose 15.28% to $196.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $686.7 million, marking a year-over-year increase of 27.31%. This contributed to the annual value of $594.1 million for FY2024, which is 56.37% up from last year.
  • Latest data reveals that BeOne Medicines reported Cost of Revenue of $594.1 million as of FY2024, which was up 56.37% from $379.9 million recorded in FY2023.
  • In the past 5 years, BeOne Medicines' Cost of Revenue ranged from a high of $594.1 million in FY2024 and a low of $70.7 million during FY2020.
  • In the last 3 years, BeOne Medicines' Cost of Revenue had a median value of $379.9 million in 2023 and averaged $420.2 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first declined by 0.75% in 2020, then spiked by 133.39% in 2021.
  • Yearly analysis of 5 years shows BeOne Medicines' Cost of Revenue stood at $70.7 million in 2020, then soared by 133.39% to $164.9 million in 2021, then surged by 73.72% to $286.5 million in 2022, then soared by 32.62% to $379.9 million in 2023, then surged by 56.37% to $594.1 million in 2024.